| PeproTech |
400-18(A) |
Recombinant rat IL-9
|
2ug |
|
|
| PeproTech |
400-06(A) |
Recombinant rat IL-6
|
2ug |
|
|
| PeproTech |
200-06R(A) |
Recombinant human sIL-6 Receptor-α
|
5ug |
|
|
| PeproTech |
200-11(A) |
Recombinant human IL-11
|
2ug |
|
|
| PeproTech |
400-19(A) |
Recombinant rat IL-10
|
2ug |
|
|
| PeproTech |
210-10(A) |
Recombinant murine IL-10
|
2ug |
|
|
| PeproTech |
200-10(A) |
Recombinant human IL-10
|
2ug |
|
|
| PeproTech |
200-05(A) |
Recombinant human IL-5
|
2ug |
|
|
| PeproTech |
215-15(A) |
Recombinant murine IL-5
|
5ug |
|
|
| PeproTech |
400-05(A) |
Recombinant rat IL-5
|
2ug |
|
|
| PeproTech |
200-06(A) |
Recombinant human IL-6
|
5ug |
|
|
| PeproTech |
216-16(A) |
Recombinant murine IL-6
|
2ug |
|
|
| PeproTech |
200-07(A) |
Recombinant human IL-7
|
2ug |
|
|
| PeproTech |
200-03(A) |
Recombinant human IL-3
|
2ug |
|
|
| PeproTech |
213-13(A) |
Recombinant murine IL-3
|
2ug |
|
|
| PeproTech |
400-03(A) |
Recombinant rat IL-3β
|
5ug |
|
|
| PeproTech |
200-04(A) |
Recombinant human IL-4
|
5ug |
|
|
| PeproTech |
214-14(A) |
Recombinant murine IL-4
|
5ug |
|
|
| PeproTech |
400-04(A) |
Recombinant rat IL-4
|
5ug |
|
|
| PeproTech |
200-04R(A) |
Recombinant human sIL-4 Receptor-α
|
3ug |
|
|
| PeproTech |
211-11B(A) |
Recombinant murine IL-1β
|
2ug |
|
|
| PeproTech |
400-01B(A) |
Recombinant rat IL-1β
|
2ug |
|
|
| PeproTech |
200-01RA(A) |
Recombinant human IL-1 Receptor Antagonist
|
20ug |
|
|
| PeproTech |
200-02(A) |
Recombinant human IL-2
|
10ug |
|
|
| PeproTech |
212-12(A) |
Recombinant murine IL-2
|
5ug |
|
|
| PeproTech |
400-02(A) |
Recombinant rat IL-2
|
5ug |
|
|
| PeproTech |
200-02R(A) |
Recombinant human sIL-2 Receptor-a
|
5ug |
|
|
| PeproTech |
100-05(A) |
Recombinant human IGF-BP5
|
5ug |
|
|
| PeproTech |
350-07B(A) |
Recombinant human IGF-BP6
|
5ug |
|
|
| PeproTech |
350-09(A) |
Recombinant human IGF-BP7
|
5ug |
|
|
| PeproTech |
200-01A(A) |
Recombinant human IL-1α
|
2ug |
|
|
| PeproTech |
211-11A(A) |
Recombinant murine IL-1α
|
2ug |
|
|
| PeproTech |
400-01A(A) |
Recombinant rat IL-1α
|
2ug |
|
|
| PeproTech |
200-01B(A) |
Recombinant human IL-1β
|
2ug |
|
|
| PeproTech |
250-19(A) |
Recombinant murine IGF-I
|
10ug |
|
|
| PeproTech |
100-12(A) |
Recombinant human IGF-II
|
10ug |
|
|
| PeproTech |
350-10(A) |
Recombinant human IGF-BP1
|
5ug |
|
|
| PeproTech |
350-06B(A) |
Recombinant human IGF-BP2
|
5ug |
|
|
| PeproTech |
100-08(A) |
Recombinant human IGF-BP3
|
5ug |
|
|
| PeproTech |
350-05B(A) |
Recombinant human IGF-BP4
|
5ug |
|
|
| PeproTech |
315-05(A) |
Recombinant murine IFN-γ
|
20ug |
|
|
| PeproTech |
400-20(A) |
Recombinant rat IFN-γ
|
20ug |
|
|
| PeproTech |
300-02L(A) |
Recombinant human IFN-λ1
|
5ug |
|
|
| PeproTech |
300-02K(A) |
Recombinant human IFN-λ2
|
5ug |
|
|
| PeproTech |
250-33(A) |
Recombinant murine IFN-λ2
|
5ug |
|
|
| PeproTech |
300-02J(A) |
Recombinant human IFN-w
|
20ug |
|
|
| PeproTech |
100-11(A) |
Recombinant human IGF-I
|
20ug |
|
|
| PeproTech |
100-47(A) |
Recombinant human HB-EGF
|
10ug |
|
|
| PeproTech |
300-38(A) |
Recombinant human HCC-1 (CCL14/72 a.a.)
|
2ug |
|
|
| PeproTech |
300-38B(A) |
Recombinant human HCC-1 (CCL14/66 a.a.)
|
2ug |
|
|